… Imaging results of PET were compared with 99m Tc-labeled hydrazinonicotinyl-Tyr 3 -octreotide
( 99m Tc-HYNIC-TOC) and 111 In-DOTA-TOC. CT was also performed on every patient …

… suggestive of NETs or with carcinoid syndrome underwent several clinical studies and were
… 99m Tc-TOC scintigraphy study. Patients without a suggestion of neuroendocrine cancer …

… Scintigraphy with 111 In- or 99m Tc-labeled somatostatin analogs has become the main …
-DTPA-octreotide. The clinical experience of these radiopharmaceuticals in endocrine tumors, ie…

… to assess the potential of 99mTc‑Hynic‑TOC imaging in the primary diagnosis and follow‑up
of midgut neuroendocrine tumors (NETs). In comparison to 111In‑octreotide, 99mTc‑Hynic‑…

… Another study, of patients with endocrine tumors, found better results for a 99m Tc-somatostatin
analog using 99m Tc-tricine-HYNIC-Tyr 3 -octreotide than for 111 In-pentetreotide (36). …

… ]octreotide has proven its role in the diagnosis and staging of gastroenteropancreatic
neuroendocrine tumors … B, Szybinski P & Kulig J 2006 99mTc-EDDA/ HYNIC-octreotate …

… -99m-octreotide (Tc-99m-OCT) in imaging neuroendocrine tumors (… In addition to the primary
tumors, the octreotide scan … The smallest lesion detected on octreotide scan was a 4-mm …

… of 25 patients with neuroendocrine tumours, with negative or weakly positive 111 In-pentetreotide
scans, who were consecutively enrolled to undergo 111 In-pentetreotide and 99m Tc-…

… neuroendocrine tumors using a series of whole-body planar, dynamic planar, and SPECT/CT
studies, after injection with 99m Tc-… as due to neuroendocrine tumors, was observed in 12 …

… 99mTc-Depreotide (Neotect ) is another commercially available somatostatin analog that …
-Aronsson E: Clinical efficacy of octreotide scintigraphy in patients with midgut carcinoid …